Starpharma is one of Bell Potter top picks for FY18, page-20

Working backwards on volumes above 500,000:

07/06/17 - Volume .83M (no news)
16/06/17 - Volume .58M (no news)
14/06/17 - Volume .71M (Agrium sale)
28/04/17 - Volume 1.42M (Appendix 4c)
21/04/17 - Volume .95M (no news)
20/04/17 - Volume 1.05M (AstraZeneca milestone payment)
01/03/17 - Volume .9M (no news)
28/02/17 - Volume .81M (no news)
27/02/17 - Volume 1.26M (Half Year financials)
14/02/17 - Volume .81M (no news)
08/02/17 - Volume .65M (no news)
24/01/17 - Volume .92M (no news)
19/01/17 - Volume .82M (shareholder update)
16/01/17 - Volume .97M (no news)
13/01/17 - Volume 1.05M (no news)
12/01/17 - Volume 1.16M (QIDP granted and FDA fast track)
10/01/17 - Volume 1.16M (no news)
04/01/17 - Volume 2.23M (no news)
06/12/16 - Volume 2.06M (no news)
05/12/16 - Volume 1.84M (change in Director notices)
02/11/16 - Volume .97M (no news)
01/11/16 - Volume 1.06M (no news)
31/10/16 - Volume 1.06M (no news)
28/10/16 - Volume 1.27M (Priostar patent and 4C)
27/10/16 - Volume 1.63M (no news)

It's easier reading it from bottom to top - starts to paint a picture (I could do more but I can't be bothered), seemingly increased volume is a precursor to news. Interesting that investors tend to follow the trend when the Directors have purchased though (check previous announcements) increasing the SP. Please DYOR.

Apologies for any errors or omissions, I was working off two websites (one with news on and one with volume info) swapping between one and the other (could only superimpose news items on one without volume) it got a little tedious after awhile....

AG